VENTRIPOINT DIAGNOSTICS LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1555 USD | -2.81% |
|
-1.14% | -31.86% |
| 06-13 | Ventripoint Diagnostics Ltd. Appoints Matt Dobson as Marketing Director | CI |
| 05-31 | Ventripoint Diagnostics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 208B | ||||||
| 182B | ||||||
| 155B | ||||||
| 115B | ||||||
| 66.52B |
